CollPlant Biotechnologies Ltd (NAS:CLGN)
$ 3.57 0.07 (2%) Market Cap: 40.89 Mil Enterprise Value: 27.97 Mil PE Ratio: 0 PB Ratio: 2.41 GF Score: 36/100

Q1 2024 Collplant Biotechnologies Ltd Earnings Call Transcript

May 29, 2024 / 02:00PM GMT
Release Date Price: $5.67 (-4.76%)
Operator

Welcome to the CollPlant Biotechnology investor conference call to discuss financial results for the first-quarter of 2024 and corporate updates. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded.

Now, I'll turn the call over to Dory Kurowski of LifeSci Advisors. Please go ahead.

Dory Kurowski
LifeSci Advisors - Investor Relations

I would like to welcome everyone to CollPlant Biotechnologies financial Results conference call to discuss the results for the first quarter ended March 31, 2024 and provide a corporate business update.

With us on the call today from CollPlant are Yehiel Tal, Chief Executive Officer, who will provide an overview of the company's programs and associated updates; and Eran Rotem, Deputy CEO and Chief Financial Officer, who will provide a summary of CollPlant's financial results for the first quarter ending March 31, 2024. Both will be available to answer questions at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot